{"transactions":[{"id":4628941,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-02T21:56:31.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":1325,"price":8.676,"value":11495.7,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award has been granted in lieu of normal quarterly cash payments. The underlying award quantity is fully vested at time of grant."}],"balance_after":1325,"derivative":{"exercise_price":10.44,"expiration_date":"2036-09-30","underlying":"Common Stock","underlying_shares":1325},"source":{"system":"sec-edgar","filing":"0001193125-26-412655","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1841387/000119312526412655/ownership.xml","form_type":"4"}},{"id":720923,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-01T20:20:42.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":1331,"price":8.639,"value":11498.509,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award has been granted in lieu of normal quarterly cash payments. The underlying award quantity is fully vested at time of grant."}],"balance_after":1331,"derivative":{"exercise_price":10.3,"exercise_date":"2026-07-01","expiration_date":"2036-06-30","underlying":"Common Stock","underlying_shares":1331},"source":{"system":"sec-edgar","filing":"0001242215-26-000018","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000124221526000018/ownership.xml","form_type":"4"}},{"id":727494,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T20:33:47.000Z","date":"2026-06-23","kind":"grant","planned":false,"acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 23, 2027 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the \"Board\") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting."}],"balance_after":32000,"derivative":{"exercise_price":9.08,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001242215-26-000016","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000124221526000016/ownership.xml","form_type":"4"}},{"id":739495,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-12T20:15:14.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":77000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on July 10, 2026, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":77000,"derivative":{"exercise_price":1.22,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":77000},"source":{"system":"sec-edgar","filing":"0001242215-26-000014","document":"form4-06122026_040609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000124221526000014/form4-06122026_040609.xml","form_type":"4"}},{"id":795404,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-05-01T20:26:19.000Z","date":"2026-04-29","kind":"grant","planned":false,"acquired":true,"shares":187708,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"The restricted stock unit grant was approved by the Compensation Committee of Emergent BioSolutions Inc. (the \"Company\"), on March 2, 2026, subject to stockholder approval of an amendment of the Company's 2006 Stock Incentive Plan (the \"Amended Stock Incentive Plan\"), under which the restricted stock units were granted. The Company's stockholders approved the Amended Stock Incentive Plan on April 29, 2026."},{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of restricted stock units granted under the Company's Amended Stock Incentive Plan. These restricted stock units vest in three annual installments beginning on the  anniversary of the date of approval, assuming continued service with the Company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":493153,"source":{"system":"sec-edgar","filing":"0001242215-26-000012","document":"wk-form4_1777667176.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000124221526000012/wk-form4_1777667176.xml","form_type":"4"}},{"id":819224,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T21:10:45.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":2795,"price":4.114,"value":11498.63,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award has been granted in lieu of normal quarterly cash payments. The underlying award quantity is fully vested at time of grant."}],"balance_after":2795,"derivative":{"exercise_price":4.9,"exercise_date":"2026-04-01","expiration_date":"2036-03-31","underlying":"Common Stock","underlying_shares":2795},"source":{"system":"sec-edgar","filing":"0001242215-26-000010","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000124221526000010/ownership.xml","form_type":"4"}},{"id":858086,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2026-03-06T02:40:29.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":252194,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":1784694,"derivative":{"exercise_price":8.99,"expiration_date":"2033-03-02","underlying":"Common Stock","underlying_shares":252194},"source":{"system":"sec-edgar","filing":"0001242215-26-000008","document":"wk-form4_1772764826.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000124221526000008/wk-form4_1772764826.xml","form_type":"4"}},{"id":858085,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-03-06T02:40:29.000Z","date":"2026-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":37055,"price":8.44,"value":312744.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes associated with vesting and settlement of performance stock units."}],"balance_after":305445,"source":{"system":"sec-edgar","filing":"0001242215-26-000008","document":"wk-form4_1772764826.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000124221526000008/wk-form4_1772764826.xml","form_type":"4"}},{"id":1087296,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Common Warrants (right to buy)","published_at":"2025-07-15T20:15:07.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 100,000 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 100,000 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":100000,"derivative":{"exercise_price":1.875,"expiration_date":"2030-07-11","underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-25-019770","document":"form4-07152025_040701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000141588925019770/form4-07152025_040701.xml","form_type":"4"}},{"id":1087295,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Common Warrants (right to buy)","published_at":"2025-07-15T20:15:07.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 100,000 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 100,000 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested and exercisable."}],"balance_after":100000,"derivative":{"exercise_price":1.5,"expiration_date":"2026-07-11","underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-25-019770","document":"form4-07152025_040701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000141588925019770/form4-07152025_040701.xml","form_type":"4"}},{"id":1087294,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-07-15T20:15:07.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 100,000 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 100,000 shares of common stock."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001415889-25-019770","document":"form4-07152025_040701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000141588925019770/form4-07152025_040701.xml","form_type":"4"}},{"id":1100948,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-26T12:30:04.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":64239,"price":4.67,"value":299996.13,"ownership":{"direct":false,"nature":"By Joseph C. Papa Revocable Living Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Joseph C. Papa Revocable Living Trust, which is wholly owned by a trust for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any."}],"balance_after":64239,"source":{"system":"sec-edgar","filing":"0000950170-25-090191","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000095017025090191/ownership.xml","form_type":"4"}},{"id":1106079,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-18T12:32:30.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":14240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 17, 2026 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the \"Board\") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting."}],"balance_after":14240,"derivative":{"exercise_price":4.94,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":14240},"source":{"system":"sec-edgar","filing":"0000950170-25-087697","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000095017025087697/ownership.xml","form_type":"4"}},{"id":1113103,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T20:19:05.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on July 10, 2025, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.75,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-25-016932","document":"form4-06122025_040611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000141588925016932/form4-06122025_040611.xml","form_type":"4"}},{"id":1147182,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-05-15T20:02:40.000Z","date":"2025-05-13","kind":"purchase","planned":false,"acquired":true,"shares":60000,"price":5.83,"value":349800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 13, 2025, Mr. Papa purchased an aggregate of 60,000 shares of Emergent BioSolutions Inc. common stock. For reporting purposes, purchase prices within a $1 range have been aggregated and the weighted average purchase price has been reported. The price ranges were: $5.76 - $5.88. The Company maintains a record of the transactions and copies will be provided upon request."}],"balance_after":342500,"source":{"system":"sec-edgar","filing":"0001367644-25-000127","document":"wk-form4_1747339349.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000136764425000127/wk-form4_1747339349.xml","form_type":"4"}},{"id":1209401,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2025-03-12T22:12:58.000Z","date":"2025-03-12","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of an award of performance stock options granted under the company's  Inducement Plan. These performance stock options vested in one annual installment on the day prior to the first anniversary of the date of grant based on the achievement of the $5 and $10 stock price performance hurdles as described in Mr. Papa's executive employment agreement dated February 19, 2024 (the \"Papa Employment Agreement\") and as certified by the company's Compensation Committee on February 12, 2025. Pursuant to the award, there remains 250,000 unvested performance stock options that are subject to a $15 stock price performance hurdle as described in the Papa Employment Agreement. Each performance stock option represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc. at the exercise price."}],"balance_after":1532500,"derivative":{"exercise_price":2.33,"exercise_date":"2025-03-12","expiration_date":"2031-03-12","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001367644-25-000058","document":"wk-form4_1741817572.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000136764425000058/wk-form4_1741817572.xml","form_type":"4"}},{"id":1209400,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2025-03-12T22:12:58.000Z","date":"2025-03-12","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of an award of performance stock options granted under the company's  Inducement Plan. These performance stock options vested in one annual installment on the day prior to the first anniversary of the date of grant based on the achievement of the $5 and $10 stock price performance hurdles as described in Mr. Papa's executive employment agreement dated February 19, 2024 (the \"Papa Employment Agreement\") and as certified by the company's Compensation Committee on February 12, 2025. Pursuant to the award, there remains 250,000 unvested performance stock options that are subject to a $15 stock price performance hurdle as described in the Papa Employment Agreement. Each performance stock option represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc. at the exercise price."}],"balance_after":1282500,"derivative":{"exercise_price":2.33,"exercise_date":"2025-03-12","expiration_date":"2031-03-12","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001367644-25-000058","document":"wk-form4_1741817572.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000136764425000058/wk-form4_1741817572.xml","form_type":"4"}},{"id":1214832,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2025-03-10T20:17:31.000Z","date":"2025-03-06","kind":"grant","planned":false,"acquired":true,"shares":282500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":1032500,"derivative":{"exercise_price":5.8,"expiration_date":"2032-03-05","underlying":"Common Stock","underlying_shares":282500},"source":{"system":"sec-edgar","filing":"0001367644-25-000048","document":"wk-form4_1741637843.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000136764425000048/wk-form4_1741637843.xml","form_type":"4"}},{"id":1214831,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-03-10T20:17:31.000Z","date":"2025-03-06","kind":"grant","planned":false,"acquired":true,"shares":282500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each performance stock unit represents a right to receive one share of common stock. The performance stock units vest in three annual installments beginning on the day prior to the  anniversary of the date of grant, assuming continued service with the company and upon achievement with respect to Adjusted EBITDA for the 2025 fiscal year, as certified by the Compensation Committee following the performance period."}],"balance_after":282500,"source":{"system":"sec-edgar","filing":"0001367644-25-000048","document":"wk-form4_1741637843.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000136764425000048/wk-form4_1741637843.xml","form_type":"4"}},{"id":1413674,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-05T20:31:10.000Z","date":"2024-09-03","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in equal monthly installments, beginning on October 3, 2024, over a period of three years, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":80000,"derivative":{"exercise_price":1.39,"expiration_date":"2034-09-03","underlying":"Common Shares","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001415889-24-022914","document":"form4-09052024_080906.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000141588924022914/form4-09052024_080906.xml","form_type":"4"}},{"id":1468029,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-27T12:41:14.000Z","date":"2024-06-26","kind":"grant","planned":false,"acquired":true,"shares":14240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 26, 2025 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the \"Board\") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting."}],"balance_after":14240,"derivative":{"exercise_price":5.71,"expiration_date":"2034-06-26","underlying":"Common Stock","underlying_shares":14240},"source":{"system":"sec-edgar","filing":"0000950170-24-078175","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000095017024078175/ownership.xml","form_type":"4"}},{"id":1574513,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2024-03-15T21:16:43.000Z","date":"2024-03-13","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 500,000 options to purchase shares granted under the Emergent BioSolutions Inc. Amended and Restated Stock Incentive Plan and 250,000 options to purchase shares granted under the Emergent BioSolutions Inc. Inducement Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":750000,"derivative":{"exercise_price":2.33,"expiration_date":"2031-03-12","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001367644-24-000045","document":"wk-form4_1710537389.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000136764424000045/wk-form4_1710537389.xml","form_type":"4"}},{"id":1841916,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-29T13:00:11.000Z","date":"2023-06-28","kind":"grant","planned":false,"acquired":true,"shares":14240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 28, 2024 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the \"Board\") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting."}],"balance_after":14240,"derivative":{"exercise_price":1.22,"expiration_date":"2033-06-28","underlying":"Common Stock","underlying_shares":14240},"source":{"system":"sec-edgar","filing":"0001209191-23-040132","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000120919123040132/doc4.xml","form_type":"4"}},{"id":1851809,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T20:00:23.000Z","date":"2023-06-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22551,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. (\"Merck\") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the \"Effective Time\"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the \"Merger Consideration\"), without interest,... (Continued in Footnote 3)"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units (\"RSUs\") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. (\"Merck\") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the \"Effective Time\"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the \"Merger Consideration\"), without interest,... (Continued in Footnote 3)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"(Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units (\"RSUs\") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option."}],"balance_after":0,"derivative":{"exercise_price":29.02,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":22551},"source":{"system":"sec-edgar","filing":"0000899243-23-015759","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000089924323015759/doc4.xml","form_type":"4"}},{"id":1851808,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T20:00:23.000Z","date":"2023-06-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2165,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. (\"Merck\") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the \"Effective Time\"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the \"Merger Consideration\"), without interest,... (Continued in Footnote 3)"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units (\"RSUs\") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. (\"Merck\") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the \"Effective Time\"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the \"Merger Consideration\"), without interest,... (Continued in Footnote 3)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"(Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units (\"RSUs\") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option."}],"balance_after":0,"derivative":{"exercise_price":36.32,"expiration_date":"2031-11-13","underlying":"Common Stock","underlying_shares":2165},"source":{"system":"sec-edgar","filing":"0000899243-23-015759","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000089924323015759/doc4.xml","form_type":"4"}},{"id":1851807,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T20:00:23.000Z","date":"2023-06-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22652,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. (\"Merck\") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the \"Effective Time\"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the \"Merger Consideration\"), without interest,... (Continued in Footnote 3)"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units (\"RSUs\") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. (\"Merck\") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the \"Effective Time\"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the \"Merger Consideration\"), without interest,... (Continued in Footnote 3)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"(Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units (\"RSUs\") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option."}],"balance_after":0,"derivative":{"exercise_price":6.7,"expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":22652},"source":{"system":"sec-edgar","filing":"0000899243-23-015759","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000089924323015759/doc4.xml","form_type":"4"}},{"id":1851806,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T20:00:23.000Z","date":"2023-06-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":27340,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. (\"Merck\") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the \"Effective Time\"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the \"Merger Consideration\"), without interest,... (Continued in Footnote 3)"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units (\"RSUs\") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. (\"Merck\") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the \"Effective Time\"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the \"Merger Consideration\"), without interest,... (Continued in Footnote 3)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"(Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units (\"RSUs\") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option."}],"balance_after":0,"derivative":{"exercise_price":3.7,"expiration_date":"2030-12-17","underlying":"Common Stock","underlying_shares":27340},"source":{"system":"sec-edgar","filing":"0000899243-23-015759","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000089924323015759/doc4.xml","form_type":"4"}},{"id":1851805,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T20:00:23.000Z","date":"2023-06-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. (\"Merck\") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the \"Effective Time\"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the \"Merger Consideration\"), without interest,... (Continued in Footnote 3)"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units (\"RSUs\") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. (\"Merck\") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the \"Effective Time\"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the \"Merger Consideration\"), without interest,... (Continued in Footnote 3)"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"(Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units (\"RSUs\") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option."}],"balance_after":0,"derivative":{"exercise_price":3.1,"expiration_date":"2030-08-24","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-23-015759","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000089924323015759/doc4.xml","form_type":"4"}},{"id":1851804,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:00:23.000Z","date":"2023-06-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":false,"nature":"By The Papa Family Charitable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. (\"Merck\") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the \"Effective Time\"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the \"Merger Consideration\"), without interest,... (Continued in Footnote 3)"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units (\"RSUs\") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Person is a Trustee to The Papa Family Charitable Trust."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-015759","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000089924323015759/doc4.xml","form_type":"4"}},{"id":1851803,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:00:23.000Z","date":"2023-06-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7278,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 2,278 restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Agreement and Plan of Merger, dated April 15, 2023, by and among the Issuer, Merck & Co., Inc. (\"Merck\") and Splash Merger Sub, Inc., the Issuer became a wholly owned subsidiary of Merck upon consummation of the merger (the \"Effective Time\"). At the Effective Time, (a) each of the Issuer's outstanding shares of common stock was cancelled and automatically converted into the right to receive $200 in cash (the \"Merger Consideration\"), without interest,... (Continued in Footnote 3)"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnote 2) ...(b) each of the Issuer's outstanding restricted stock units (\"RSUs\") was automatically cancelled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of the Issuer's common stock underlying such RSU immediately prior to the Effective Time multiplied by (ii) the Merger Consideration, without interest and (c) each of the Issuer's outstanding unexercised stock options, whether vested or unvested, was automatically cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the number of shares of the Issuer's common stock underlying such option immediately prior to the Effective Time multiplied by (ii) the amount, if any, by which the Merger Consideration exceeded the exercise price per share of such option."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-015759","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000089924323015759/doc4.xml","form_type":"4"}},{"id":1869363,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T22:43:37.000Z","date":"2023-06-02","kind":"other","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By The Papa Family Charitable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer of shares from the Reporting Person to The Papa Family Charitable Trust."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is a Trustee to The Papa Family Charitable Trust."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-23-034004","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000120919123034004/doc4.xml","form_type":"4"}},{"id":1869362,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T22:43:37.000Z","date":"2023-06-02","kind":"other","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer of shares from the Reporting Person to The Papa Family Charitable Trust."}],"balance_after":7278,"source":{"system":"sec-edgar","filing":"0001209191-23-034004","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000120919123034004/doc4.xml","form_type":"4"}},{"id":1884308,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-19T21:44:11.000Z","date":"2023-05-19","kind":"grant","planned":false,"acquired":true,"shares":2278,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of restricted stock units (\"RSUs\") granted under the Issuer's 2021 Incentive Award Plan (the \"2021 Plan\").  Each RSU entitles the Reporting Person to receive one share of Issuer common stock upon vesting.  The RSUs shall vest in full upon the earlier to occur of (i) the first anniversary of the date of grant, (ii) the Issuer's next occurring annual meeting of stockholders, or (iii) a Change of Control (as defined in the 2021 Plan), subject to the Reporting Person's continued service with the Issuer on such vesting date."}],"balance_after":17278,"source":{"system":"sec-edgar","filing":"0001209191-23-031188","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000120919123031188/doc4.xml","form_type":"4"}},{"id":2089468,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-12T21:25:33.000Z","date":"2022-12-09","kind":"purchase","acquired":true,"shares":35018,"price":1.94,"value":67934.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.85 to $2.00. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":38032,"source":{"system":"sec-edgar","filing":"0001209191-22-060694","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000120919122060694/doc4.xml","form_type":"4"}},{"id":2089467,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-12T21:25:33.000Z","date":"2022-12-08","kind":"purchase","acquired":true,"shares":3014,"price":1.7,"value":5123.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.55 to $1.80. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":3014,"source":{"system":"sec-edgar","filing":"0001209191-22-060694","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000120919122060694/doc4.xml","form_type":"4"}},{"id":2189224,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-10T12:05:13.000Z","date":"2022-08-08","kind":"grant","acquired":true,"shares":28480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33% of the shares underlying this option shall vest and become exercisable on August 8, 2023, with the remainder vesting in two (2) equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":28480,"derivative":{"exercise_price":3.38,"expiration_date":"2032-08-08","underlying":"Common Stock","underlying_shares":28480},"source":{"system":"sec-edgar","filing":"0000899243-22-028201","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000089924322028201/doc4.xml","form_type":"4"}},{"id":2261584,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-20T23:26:39.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":22551,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest in full upon the earlier to occur of (i) the first anniversary of the grant date or (ii) the Issuer's next annual meeting of stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer on such vesting date."}],"balance_after":22551,"derivative":{"exercise_price":29.02,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":22551},"source":{"system":"sec-edgar","filing":"0001209191-22-031176","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000120919122031176/doc4.xml","form_type":"4"}},{"id":2274086,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2022-05-13T01:12:59.000Z","date":"2022-05-10","kind":"exercise","acquired":false,"shares":65911,"price":9.4,"value":619563.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each PSU converts into Common Shares on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects the vesting and conversion of certain \"Separation PSUs\", previously granted to the reporting person on March 3, 2021, into common shares, no par value (\"Common Shares\") of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects the vesting and conversion of certain \"Separation PSUs\", previously granted to the reporting person on March 3, 2021, into common shares, no par value (\"Common Shares\") of the Issuer."}],"balance_after":0,"derivative":{"expiration_date":"2022-05-10","underlying":"Common Shares, No Par Value","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0000899243-22-017885","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/885590/000089924322017885/doc4.xml","form_type":"4"}},{"id":2274085,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2022-05-13T01:12:59.000Z","date":"2022-05-10","kind":"grant","acquired":true,"shares":65911,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each PSU converts into Common Shares on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects the vesting and conversion of certain \"Separation PSUs\", previously granted to the reporting person on March 3, 2021, into common shares, no par value (\"Common Shares\") of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each PSU converts into Common Shares on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects the vesting and conversion of certain \"Separation PSUs\", previously granted to the reporting person on March 3, 2021, into common shares, no par value (\"Common Shares\") of the Issuer."}],"balance_after":0,"derivative":{"expiration_date":"2022-05-10","underlying":"Common Shares, No Par Value","underlying_shares":65911},"source":{"system":"sec-edgar","filing":"0000899243-22-017885","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/885590/000089924322017885/doc4.xml","form_type":"4"}},{"id":2274084,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2022-05-13T01:12:59.000Z","date":"2022-05-10","kind":"exercise","acquired":false,"shares":183522,"price":9.4,"value":1725106.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each PSU converts into Common Shares on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects an award of PSUs, previously granted to the reporting person on March 3, 2021, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on March 3, 2023, subject to the reporting person's continuous service."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects an award of PSUs, previously granted to the reporting person on March 3, 2021, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on March 3, 2023, subject to the reporting person's continuous service."}],"balance_after":0,"derivative":{"expiration_date":"2022-05-10","underlying":"Common Shares, No Par Value","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0000899243-22-017885","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/885590/000089924322017885/doc4.xml","form_type":"4"}},{"id":2274083,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2022-05-13T01:12:59.000Z","date":"2022-05-10","kind":"grant","acquired":true,"shares":183522,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each PSU converts into Common Shares on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects an award of PSUs, previously granted to the reporting person on March 3, 2021, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on March 3, 2023, subject to the reporting person's continuous service."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each PSU converts into Common Shares on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects an award of PSUs, previously granted to the reporting person on March 3, 2021, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on March 3, 2023, subject to the reporting person's continuous service."}],"balance_after":0,"derivative":{"expiration_date":"2022-05-10","underlying":"Common Shares, No Par Value","underlying_shares":183522},"source":{"system":"sec-edgar","filing":"0000899243-22-017885","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/885590/000089924322017885/doc4.xml","form_type":"4"}},{"id":2274082,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2022-05-13T01:12:59.000Z","date":"2022-05-10","kind":"exercise","acquired":false,"shares":116697,"price":9.4,"value":1096951.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each PSU converts into Common Shares on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of performance-based Restricted Share Units (\"PSUs\"), previously granted to the reporting person on February 26, 2020, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on February 26, 2023, subject to the reporting person's continuous service."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects an award of performance-based Restricted Share Units (\"PSUs\"), previously granted to the reporting person on February 26, 2020, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on February 26, 2023, subject to the reporting person's continuous service."}],"balance_after":0,"derivative":{"expiration_date":"2022-05-10","underlying":"Common Shares, No Par Value","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0000899243-22-017885","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885590/000089924322017885/doc4.xml","form_type":"4"}},{"id":2274081,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2022-05-13T01:12:59.000Z","date":"2022-05-10","kind":"grant","acquired":true,"shares":116697,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each PSU converts into Common Shares on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of performance-based Restricted Share Units (\"PSUs\"), previously granted to the reporting person on February 26, 2020, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on February 26, 2023, subject to the reporting person's continuous service."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each PSU converts into Common Shares on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects an award of performance-based Restricted Share Units (\"PSUs\"), previously granted to the reporting person on February 26, 2020, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on February 26, 2023, subject to the reporting person's continuous service."}],"balance_after":0,"derivative":{"expiration_date":"2022-05-10","underlying":"Common Shares, No Par Value","underlying_shares":116697},"source":{"system":"sec-edgar","filing":"0000899243-22-017885","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885590/000089924322017885/doc4.xml","form_type":"4"}},{"id":2274080,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares, No Par Value","published_at":"2022-05-13T01:12:59.000Z","date":"2022-05-10","kind":"tax_withholding","acquired":false,"shares":33714,"price":9.4,"value":316911.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of the reporting person's Separation PSUs."}],"balance_after":1427568,"source":{"system":"sec-edgar","filing":"0000899243-22-017885","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885590/000089924322017885/doc4.xml","form_type":"4"}},{"id":2274079,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares, No Par Value","published_at":"2022-05-13T01:12:59.000Z","date":"2022-05-10","kind":"exercise","acquired":true,"shares":65911,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects the vesting and conversion of certain \"Separation PSUs\", previously granted to the reporting person on March 3, 2021, into common shares, no par value (\"Common Shares\") of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each PSU converts into Common Shares on a one-for-one basis."}],"balance_after":1461282,"source":{"system":"sec-edgar","filing":"0000899243-22-017885","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885590/000089924322017885/doc4.xml","form_type":"4"}},{"id":2274078,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares, No Par Value","published_at":"2022-05-13T01:12:59.000Z","date":"2022-05-10","kind":"exercise","acquired":true,"shares":183522,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects an award of PSUs, previously granted to the reporting person on March 3, 2021, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on March 3, 2023, subject to the reporting person's continuous service."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each PSU converts into Common Shares on a one-for-one basis."}],"balance_after":1395371,"source":{"system":"sec-edgar","filing":"0000899243-22-017885","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000089924322017885/doc4.xml","form_type":"4"}},{"id":2274077,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares, No Par Value","published_at":"2022-05-13T01:12:59.000Z","date":"2022-05-10","kind":"exercise","acquired":true,"shares":116697,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of performance-based Restricted Share Units (\"PSUs\"), previously granted to the reporting person on February 26, 2020, that was earned upon the certification of performance metrics applicable to such PSUs. The earned PSUs will vest on February 26, 2023, subject to the reporting person's continuous service."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each PSU converts into Common Shares on a one-for-one basis."}],"balance_after":1211849,"source":{"system":"sec-edgar","filing":"0000899243-22-017885","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000089924322017885/doc4.xml","form_type":"4"}},{"id":2278007,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & Chairman"}}],"security":"Non-Qualified Stock Options (right to purchase)","published_at":"2022-05-09T22:45:56.000Z","date":"2022-05-05","kind":"grant","acquired":true,"shares":1868131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the grant of stock options to purchase Common Shares under the Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The stock options will expire on the tenth anniversary of the grant date."}],"balance_after":1868131,"derivative":{"exercise_price":18,"underlying":"Common Shares, No Par Value","underlying_shares":1868131},"source":{"system":"sec-edgar","filing":"0000899243-22-017320","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000089924322017320/doc4.xml","form_type":"4"}},{"id":2278006,"issuer":{"id":3756,"kind":"organization","name":"Bausch & Lomb Corp"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & Chairman"}}],"security":"Common Shares, No Par Value","published_at":"2022-05-09T22:45:56.000Z","date":"2022-05-05","kind":"grant","acquired":true,"shares":472222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the \"Plan\"). Vested RSUs are settled in common shares, no par value (\"Common Shares\"), of Bausch + Lomb Corporation."}],"balance_after":472222,"source":{"system":"sec-edgar","filing":"0000899243-22-017320","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1860742/000089924322017320/doc4.xml","form_type":"4"}},{"id":2348800,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2022-03-07T22:34:51.000Z","date":"2022-03-03","kind":"tax_withholding","acquired":false,"shares":12643,"price":23.61,"value":298501.23,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":1095152,"source":{"system":"sec-edgar","filing":"0001127602-22-008488","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760222008488/form4.xml","form_type":"4"}},{"id":2362814,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Restricted Share Units","published_at":"2022-03-03T02:38:54.000Z","date":"2022-02-27","kind":"exercise","acquired":false,"shares":208231,"price":24.35,"value":5070424.85,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the vesting and conversion of performance-based Restricted Share Units (\"PSUs\"), previously granted to the reporting person, into common shares, no par value (\"Common Shares\") of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":24.35,"expiration_date":"2022-02-27","underlying":"Common Shares, No Par Value","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0000899243-22-008833","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/885590/000089924322008833/doc4.xml","form_type":"4"}},{"id":2362813,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Restricted Share Units","published_at":"2022-03-03T02:38:54.000Z","date":"2022-02-27","kind":"grant","acquired":true,"shares":208231,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU converts into Common Shares on a one-for-one basis"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each PSU converts into Common Shares on a one-for-one basis"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects the vesting and conversion of performance-based Restricted Share Units (\"PSUs\"), previously granted to the reporting person, into common shares, no par value (\"Common Shares\") of the Issuer."}],"balance_after":0,"derivative":{"expiration_date":"2022-02-27","underlying":"Common Shares, No Par Value","underlying_shares":208231},"source":{"system":"sec-edgar","filing":"0000899243-22-008833","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885590/000089924322008833/doc4.xml","form_type":"4"}},{"id":2362812,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2022-03-03T02:38:54.000Z","date":"2022-02-28","kind":"tax_withholding","acquired":false,"shares":5115,"price":24.06,"value":123066.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of RSUs."}],"balance_after":1107795,"source":{"system":"sec-edgar","filing":"0000899243-22-008833","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885590/000089924322008833/doc4.xml","form_type":"4"}},{"id":2362811,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2022-03-03T02:38:54.000Z","date":"2022-02-27","kind":"tax_withholding","acquired":false,"shares":13206,"price":24.35,"value":321566.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of RSUs."}],"balance_after":1112910,"source":{"system":"sec-edgar","filing":"0000899243-22-008833","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885590/000089924322008833/doc4.xml","form_type":"4"}},{"id":2362810,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2022-03-03T02:38:54.000Z","date":"2022-02-26","kind":"tax_withholding","acquired":false,"shares":13183,"price":24.35,"value":321006.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units (\"RSUs\")."}],"balance_after":1126116,"source":{"system":"sec-edgar","filing":"0000899243-22-008833","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885590/000089924322008833/doc4.xml","form_type":"4"}},{"id":2362809,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2022-03-03T02:38:54.000Z","date":"2022-02-27","kind":"tax_withholding","acquired":false,"shares":100351,"price":24.35,"value":2443546.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs."}],"balance_after":1139299,"source":{"system":"sec-edgar","filing":"0000899243-22-008833","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000089924322008833/doc4.xml","form_type":"4"}},{"id":2362808,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2022-03-03T02:38:54.000Z","date":"2022-02-27","kind":"exercise","acquired":true,"shares":208231,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the vesting and conversion of performance-based Restricted Share Units (\"PSUs\"), previously granted to the reporting person, into common shares, no par value (\"Common Shares\") of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each PSU converts into Common Shares on a one-for-one basis"}],"balance_after":1239650,"source":{"system":"sec-edgar","filing":"0000899243-22-008833","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000089924322008833/doc4.xml","form_type":"4"}},{"id":2510297,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-17T02:15:06.000Z","date":"2021-11-14","kind":"grant","acquired":true,"shares":2165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the first anniversary of the vesting commencement date measured from November 14, 2021, subject to the Reporting Person's continued service with the Issuer on such vesting date."}],"balance_after":2165,"derivative":{"exercise_price":36.32,"expiration_date":"2031-11-13","underlying":"Common Stock","underlying_shares":2165},"source":{"system":"sec-edgar","filing":"0001209191-21-064939","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000120919121064939/doc4.xml","form_type":"4"}},{"id":2570048,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2021-09-15T21:15:50.000Z","date":"2021-09-14","kind":"tax_withholding","acquired":false,"shares":5010,"price":28.66,"value":143586.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":1031419,"source":{"system":"sec-edgar","filing":"0001127602-21-025347","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221025347/form4.xml","form_type":"4"}},{"id":2570047,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2021-09-15T21:15:50.000Z","date":"2021-09-13","kind":"tax_withholding","acquired":false,"shares":3549,"price":29.19,"value":103595.31,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":1036429,"source":{"system":"sec-edgar","filing":"0001127602-21-025347","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221025347/form4.xml","form_type":"4"}},{"id":2785816,"issuer":{"id":112175,"kind":"organization","name":"Prometheus Biosciences, Inc.","symbol":"RXDX"},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-17T01:48:53.000Z","date":"2021-03-16","kind":"purchase","acquired":true,"shares":15000,"price":19,"value":285000.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001209191-21-021218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1242215/000120919121021218/doc4.xml","form_type":"4"}},{"id":2798014,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Units","published_at":"2021-03-11T02:01:52.000Z","date":"2021-03-08","kind":"exercise","acquired":false,"shares":317089,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU converts into Common Shares on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each PSU converts into Common Shares on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"This PSU award was previously reported on a Form 4 filed on March 9, 2018 with the maximum potential award amount of 511,434 shares. Any portion of the award not vested as of the transaction date was cancelled as of that date."}],"balance_after":0,"derivative":{"expiration_date":"2021-03-07","underlying":"Common Stock","underlying_shares":317089},"source":{"system":"sec-edgar","filing":"0001127602-21-010168","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221010168/form4.xml","form_type":"4"}},{"id":2798013,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2021-03-11T02:01:52.000Z","date":"2021-03-10","kind":"tax_withholding","acquired":false,"shares":231188,"price":32.97,"value":7622268.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs and RSUs."}],"balance_after":1039978,"source":{"system":"sec-edgar","filing":"0001127602-21-010168","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221010168/form4.xml","form_type":"4"}},{"id":2798012,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2021-03-11T02:01:52.000Z","date":"2021-03-08","kind":"grant","acquired":true,"shares":108254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects common shares, no par value (\"Common Shares\") of Bausch Health Companies Inc. (the \"Company\") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units (\"PSUs\") granted to the reporting person on March 7, 2018."}],"balance_after":1271166,"source":{"system":"sec-edgar","filing":"0001127602-21-010168","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221010168/form4.xml","form_type":"4"}},{"id":2798011,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2021-03-11T02:01:52.000Z","date":"2021-03-08","kind":"exercise","acquired":true,"shares":317089,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects common shares, no par value (\"Common Shares\") of Bausch Health Companies Inc. (the \"Company\") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units (\"PSUs\") granted to the reporting person on March 7, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each PSU converts into Common Shares on a one-for-one basis."}],"balance_after":1162912,"source":{"system":"sec-edgar","filing":"0001127602-21-010168","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221010168/form4.xml","form_type":"4"}},{"id":2807333,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Non-qualified Stock Options (right To Purchase)","published_at":"2021-03-05T23:00:56.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":196464,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in equal installments on each of the first three anniversaries of the date of grant."}],"balance_after":196464,"derivative":{"exercise_price":32.56,"expiration_date":"2031-03-03","underlying":"Common Shares, No Par Value","underlying_shares":196464},"source":{"system":"sec-edgar","filing":"0001127602-21-009570","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221009570/form4.xml","form_type":"4"}},{"id":2807332,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2021-03-05T23:00:56.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":74150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc."}],"balance_after":845823,"source":{"system":"sec-edgar","filing":"0001127602-21-009570","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221009570/form4.xml","form_type":"4"}},{"id":2816445,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2021-03-03T21:47:40.000Z","date":"2021-03-01","kind":"tax_withholding","acquired":false,"shares":28192,"price":31.42,"value":885792.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":771673,"source":{"system":"sec-edgar","filing":"0001127602-21-009214","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760221009214/form4.xml","form_type":"4"}},{"id":3030697,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2020-09-16T20:09:04.000Z","date":"2020-09-15","kind":"tax_withholding","acquired":false,"shares":5115,"price":15.91,"value":81379.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":799865,"source":{"system":"sec-edgar","filing":"0001127602-20-025186","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220025186/form4.xml","form_type":"4"}},{"id":3030696,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2020-09-16T20:09:04.000Z","date":"2020-09-14","kind":"tax_withholding","acquired":false,"shares":3623,"price":15.4,"value":55794.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":804980,"source":{"system":"sec-edgar","filing":"0001127602-20-025186","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220025186/form4.xml","form_type":"4"}},{"id":3160054,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2020-05-06T20:02:26.000Z","date":"2020-05-04","kind":"tax_withholding","acquired":false,"shares":95489,"price":17.16,"value":1638591.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares, no par value, of the Issuer (\"Common Shares\") withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units (\"RSUs\")."}],"balance_after":808603,"source":{"system":"sec-edgar","filing":"0001127602-20-015620","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220015620/form4.xml","form_type":"4"}},{"id":3216544,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2020-03-12T01:03:42.000Z","date":"2020-03-09","kind":"tax_withholding","acquired":false,"shares":18488,"price":20.96,"value":387508.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":904092,"source":{"system":"sec-edgar","filing":"0001127602-20-010331","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220010331/form4.xml","form_type":"4"}},{"id":3235079,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2020-03-03T22:28:20.000Z","date":"2020-03-02","kind":"tax_withholding","acquired":false,"shares":4925,"price":22.52,"value":110911.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":922580,"source":{"system":"sec-edgar","filing":"0001127602-20-009143","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220009143/form4.xml","form_type":"4"}},{"id":3235078,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2020-03-03T22:28:20.000Z","date":"2020-02-28","kind":"tax_withholding","acquired":false,"shares":9269,"price":24.44,"value":226534.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":927505,"source":{"system":"sec-edgar","filing":"0001127602-20-009143","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220009143/form4.xml","form_type":"4"}},{"id":3242187,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Non-qualified Stock Options (right To Purchase)","published_at":"2020-02-29T00:33:16.000Z","date":"2020-02-26","kind":"grant","acquired":true,"shares":341114,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in equal installments on each of the first three anniversaries of the date of grant."}],"balance_after":341114,"derivative":{"exercise_price":24.77,"expiration_date":"2030-02-26","underlying":"Common Shares, No Par Value","underlying_shares":341114},"source":{"system":"sec-edgar","filing":"0001127602-20-008451","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220008451/form4.xml","form_type":"4"}},{"id":3242186,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2020-02-29T00:33:16.000Z","date":"2020-02-26","kind":"grant","acquired":true,"shares":81040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value (\"Common Shares\"), of Bausch Health Companies Inc. (\"Bausch Health\")."}],"balance_after":936774,"source":{"system":"sec-edgar","filing":"0001127602-20-008451","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760220008451/form4.xml","form_type":"4"}},{"id":3411312,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2019-09-18T21:08:54.000Z","date":"2019-09-16","kind":"tax_withholding","acquired":false,"shares":5115,"price":23.24,"value":118872.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":855734,"source":{"system":"sec-edgar","filing":"0001127602-19-028755","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760219028755/form4.xml","form_type":"4"}},{"id":3415377,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2019-09-14T01:06:36.000Z","date":"2019-09-13","kind":"grant","acquired":true,"shares":21248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents matching Restricted Share Units (\"MRSUs\") granted to the Reporting Person in connection with the open market purchase of Common Shares of the Issuer reported on  Table I (the \"Purchased Shares\"), pursuant to the Issuer's Matching Share Program.  One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant (\"MRSU Grant Date\"), subject to the Reporting Person's continued service (except in limited circumstances)."}],"balance_after":860849,"source":{"system":"sec-edgar","filing":"0001127602-19-028360","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760219028360/form4.xml","form_type":"4"}},{"id":3415376,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2019-09-14T01:06:36.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":30000,"price":23.31,"value":699300.0,"ownership":{"direct":true},"balance_after":839601,"source":{"system":"sec-edgar","filing":"0001127602-19-028360","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760219028360/form4.xml","form_type":"4"}},{"id":3600410,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2019-03-12T20:40:36.000Z","date":"2019-03-08","kind":"tax_withholding","acquired":false,"shares":18658,"price":23.56,"value":439582.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":809601,"source":{"system":"sec-edgar","filing":"0001127602-19-011053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760219011053/form4.xml","form_type":"4"}},{"id":3624672,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Non-qualified Stock Options (right To Purchase)","published_at":"2019-03-01T22:14:50.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":236183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in equal installments on each of the first three anniversaries of the date of grant."}],"balance_after":236183,"derivative":{"exercise_price":23.16,"expiration_date":"2029-02-27","underlying":"Common Shares, No Par Value","underlying_shares":236183},"source":{"system":"sec-edgar","filing":"0001127602-19-009258","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760219009258/form4.xml","form_type":"4"}},{"id":3624671,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2019-03-01T22:14:50.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":81182,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value (\"Common Shares\"), of Bausch Health Companies Inc. (\"Bausch Health\")."}],"balance_after":768259,"source":{"system":"sec-edgar","filing":"0001127602-19-009258","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760219009258/form4.xml","form_type":"4"}},{"id":3627495,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2019-02-28T21:10:18.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":747077,"source":{"system":"sec-edgar","filing":"0001127602-19-008918","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760219008918/form4.xml","form_type":"4"}},{"id":3627494,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2019-02-28T21:10:18.000Z","date":"2019-02-28","kind":"purchase","acquired":true,"shares":30000,"price":23.67,"value":710100.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents matching Restricted Share Units (\"MRSUs\") granted to the Reporting Person in connection with the open market purchase of Common Shares of the Issuer reported on  Table I (the \"Purchased Shares\"), pursuant to the Issuer's Matching Share Program.  One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant (\"MRSU Grant Date\"), subject to the Reporting Person's continued service (except in limited circumstances)."}],"balance_after":717077,"source":{"system":"sec-edgar","filing":"0001127602-19-008918","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760219008918/form4.xml","form_type":"4"}},{"id":3814836,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2018-09-17T18:56:12.000Z","date":"2018-09-14","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents matching Restricted Share Units (\"MRSUs\") granted to the Reporting Person in connection with the open market purchase of Common Shares of the Issuer reported on  Table I (the \"Purchased Shares\"), pursuant to the Issuer's Matching Share Program.  One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant (\"MRSU Grant Date\"), subject to the Reporting Person's continued service (except in limited circumstances)."}],"balance_after":687077,"source":{"system":"sec-edgar","filing":"0001127602-18-027734","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760218027734/form4.xml","form_type":"4"}},{"id":3814835,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2018-09-17T18:56:12.000Z","date":"2018-09-14","kind":"purchase","acquired":true,"shares":30000,"price":22.32,"value":669600.0,"ownership":{"direct":true},"balance_after":657077,"source":{"system":"sec-edgar","filing":"0001127602-18-027734","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760218027734/form4.xml","form_type":"4"}},{"id":3946116,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2018-05-04T21:55:57.000Z","date":"2018-05-03","kind":"tax_withholding","acquired":false,"shares":91942,"price":18.31,"value":1683458.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units."}],"balance_after":627077,"source":{"system":"sec-edgar","filing":"0001127602-18-016408","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760218016408/form4.xml","form_type":"4"}},{"id":3999475,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2018-03-13T20:38:50.000Z","date":"2018-03-13","kind":"purchase","acquired":true,"shares":30000,"price":16.05,"value":481500.0,"ownership":{"direct":true},"balance_after":719019,"source":{"system":"sec-edgar","filing":"0001127602-18-011391","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760218011391/form4.xml","form_type":"4"}},{"id":4004281,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Restricted Share Units","published_at":"2018-03-10T01:47:18.000Z","date":"2018-03-07","kind":"grant","acquired":true,"shares":511434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Represents a grant of performance-based RSUs. The target number of performance-based RSUs granted to the reporting person was 255,717 and the maximum number that can be distributed is 511,434. The performance-based RSUs shall vest and be distributed between 0-200% of target based on Valeant's Total Shareholder Return (\"TSR\") as measured for the 20 trading days preceding the TSR Measurement Date (\"Measurement Date\") which is the third anniversary of the grant date (March 7, 2021). If Valeant's TSR for the period between the grant date and the Measurement Date is below the 50th percentile ranking of the TSR for the applicable peer group based on the 20 trading days preceding the Measurement Date, the reporting person will receive no more than the number of Common Shares equal to the target number of performance-based RSUs subject to the award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents a grant of performance-based RSUs. The target number of performance-based RSUs granted to the reporting person was 255,717 and the maximum number that can be distributed is 511,434. The performance-based RSUs shall vest and be distributed between 0-200% of target based on Valeant's Total Shareholder Return (\"TSR\") as measured for the 20 trading days preceding the TSR Measurement Date (\"Measurement Date\") which is the third anniversary of the grant date (March 7, 2021). If Valeant's TSR for the period between the grant date and the Measurement Date is below the 50th percentile ranking of the TSR for the applicable peer group based on the 20 trading days preceding the Measurement Date, the reporting person will receive no more than the number of Common Shares equal to the target number of performance-based RSUs subject to the award."}],"balance_after":511434,"derivative":{"expiration_date":"2021-03-07","underlying":"Common Stock","underlying_shares":511434},"source":{"system":"sec-edgar","filing":"0001127602-18-011033","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760218011033/form4.xml","form_type":"4"}},{"id":4004280,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Non-qualified Stock Options (right To Purchase)","published_at":"2018-03-10T01:47:18.000Z","date":"2018-03-07","kind":"grant","acquired":true,"shares":338058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest in equal installments on each of the first three anniversaries of the date of grant."}],"balance_after":338058,"derivative":{"exercise_price":15.32,"expiration_date":"2028-03-07","underlying":"Common Shares, No Par Value","underlying_shares":338058},"source":{"system":"sec-edgar","filing":"0001127602-18-011033","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760218011033/form4.xml","form_type":"4"}},{"id":4004279,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":33888,"kind":"person","name":"PAPA JOSEPH C","position":1,"cik":"0001242215","reported_name":"PAPA JOSEPH C","relationship":{"director":true,"officer":true,"officer_title":"CHAIRMAN & CEO"}}],"security":"Common Shares, No Par Value","published_at":"2018-03-10T01:47:18.000Z","date":"2018-03-07","kind":"grant","acquired":true,"shares":113652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value (\"Common Shares\"), of Valeant Pharmaceuticals International, Inc. (\"Valeant\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the cancellation, on March 7, 2018, of 933,416 performance-based RSUs granted on May 2, 2016, as reported on a Form 4 filed by the reporting person on May 4, 2016."}],"balance_after":689019,"source":{"system":"sec-edgar","filing":"0001127602-18-011033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760218011033/form4.xml","form_type":"4"}}]}